Skip to main content
Livermore
Livermore
ZHEN

Vanguard Group Inc

SEC CIK
0000102909
Latest filing
Jan 29, 2026

UBX holding history

Unity Biotechnology, Inc. in every 13F filed by Vanguard Group Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

UBX overviewAll 13F holders of UBXFull Q4 2025 holdings

Shares (Q3 2025)
0
Sold out in Q3 2025
Value
$0
% of portfolio
0.0%
Quarters held
18
Since Q1 2021
Holdings of UBX by Vanguard Group Inc, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q3 20250$00.0%−673,090−100.0%Sold outHolders
Q2 2025673,090$255.8K<0.1%00.0%UnchangedHolders
Q1 2025673,090$700.0K<0.1%+82,320+13.9%AddedHolders
Q4 2024590,770$576.6K<0.1%00.0%UnchangedHolders
Q3 2024590,770$868.4K<0.1%00.0%UnchangedHolders
Q2 2024590,770$797.5K<0.1%+33,417+6.0%AddedHolders
Q1 2024557,353$914.1K<0.1%−4,249−0.8%ReducedHolders
Q4 2023561,602$1.08M<0.1%00.0%UnchangedHolders
Q3 2023561,602$1.35M<0.1%−1,356−0.2%ReducedHolders
Q2 2023562,958$1.44M<0.1%+39,034+7.5%AddedHolders
Q1 2023523,924$854.0K<0.1%+80,100+18.0%AddedHolders
Q4 2022443,824$1.22M<0.1%00.0%UnchangedConverted for a 1-for-10 splitHolders
Q3 20224,437,259$1.75M<0.1%+3,155,586+246.2%AddedHolders
Q2 20221,281,673$723.0K<0.1%+156,478+13.9%AddedHolders
Q1 20221,125,195$1.26M<0.1%−653,614−36.7%ReducedHolders
Q4 20211,778,809$2.60M<0.1%+369,430+26.2%AddedHolders
Q3 20211,409,379$4.23M<0.1%−8,554−0.6%ReducedHolders
Q2 20211,417,933$6.58M<0.1%−165,099−10.4%ReducedHolders
Q1 20211,583,032$9.50M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.